Literature DB >> 17020803

Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia.

Laura B Dunn1, Barton W Palmer, Paul S Appelbaum, Elyn R Saks, Gregory A Aarons, Dilip V Jeste.   

Abstract

Despite the availability of structured decision-making capacity assessment tools, insufficient guidance exists for applying their results. Investigators often use cutpoints on these instruments to identify potential subjects in need of further assessment or education. Yet, information is lacking regarding the effects of different cutpoints on the proportion and characteristics of individuals categorized as possessing adequate or impaired decisional abilities for consent to research. To demonstrate the potential impact of different standards, we informed 91 individuals, aged 50 or older with a diagnosis of schizophrenia or schizoaffective disorder, about a hypothetical clinical trial, and assessed their decisional abilities with the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR). Three published MacCAT-CR-based standards were applied to participants' scores to examine the rates and correlates of categorical determinations of adequate performance. The three standards ranged in stringency: the most stringent incorporated cutpoints on all three of the major MacCAT-CR subscales (Understanding, Appreciation, and Reasoning); the other two standards required threshold performance only on the Understanding subscale. The most stringent standard resulted in a 57% rate of impaired performance; the intermediate standard, 19%; and the least stringent standard, 8%. Nearly half of the participants (n=45) were classified as having performed adequately by the least stringent standard yet inadequately by the most stringent. The majority of these 45 were impaired on the Appreciation subscale (n=9), Reasoning (n=15), or both (n=18). Cognitive functioning was correlated with performance status for the more stringent standards. These findings underscore the need for refinement of capacity assessment procedures and for improvements in the use of capacity assessment tools for screening purposes and to assist in categorical capacity determinations.

Entities:  

Mesh:

Year:  2006        PMID: 17020803      PMCID: PMC1850805          DOI: 10.1016/j.schres.2006.08.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  40 in total

1.  An NIMH commentary on the NBAC report.

Authors:  D Shore; S E Hyman
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

Review 2.  The capacity to consent to treatment and research: a review of standardized assessment tools.

Authors:  Edward D Sturman
Journal:  Clin Psychol Rev       Date:  2005-11

3.  Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.

Authors:  Barton W Palmer; Laura B Dunn; Paul S Appelbaum; Sunder Mudaliar; Leon Thal; Robert Henry; Shahrokh Golshan; Dilip V Jeste
Journal:  Arch Gen Psychiatry       Date:  2005-07

4.  Capacity of forensic patients to consent to research: the use of the MacCAT-CR.

Authors:  Barbara E McDermott; Joan B Gerbasi; Cameron Quanbeck; Charles L Scott
Journal:  J Am Acad Psychiatry Law       Date:  2005

5.  Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.

Authors:  Scott Stroup; Paul Appelbaum; Marvin Swartz; Mukesh Patel; Sonia Davis; Dilip Jeste; Scott Kim; Richard Keefe; Theo Manschreck; Joseph McEvoy; Jeffrey Lieberman
Journal:  Schizophr Res       Date:  2005-09-22       Impact factor: 4.939

6.  When does decisional impairment become decisional incompetence? Ethical and methodological issues in capacity research in schizophrenia.

Authors:  Scott Y H Kim
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

7.  Decisional capacity of patients with schizophrenia to consent to research: taking stock.

Authors:  Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

8.  Coercion and informed consent in research involving prisoners.

Authors:  David J Moser; Stephan Arndt; Jason E Kanz; Michelle L Benjamin; John D Bayless; Rebecca L Reese; Jane S Paulsen; Michael A Flaum
Journal:  Compr Psychiatry       Date:  2004 Jan-Feb       Impact factor: 3.735

9.  Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.

Authors:  Barton W Palmer; Laura B Dunn; Paul S Appelbaum; Dilip V Jeste
Journal:  Arch Gen Psychiatry       Date:  2004-03

10.  Competence to consent to research among long-stay inpatients with chronic schizophrenia.

Authors:  Jeffrey A Kovnick; Paul S Appelbaum; Steven K Hoge; Robert A Leadbetter
Journal:  Psychiatr Serv       Date:  2003-09       Impact factor: 3.084

View more
  13 in total

1.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

Review 2.  Psychopharmacology of aggression in schizophrenia.

Authors:  Peter Buckley; Leslie Citrome; Carmen Nichita; Michael Vitacco
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

3.  [Research on humans suffering from dementia].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2015-09       Impact factor: 1.214

4.  Assessment of Capacity to Consent to Research Among Psychiatric Outpatients: Prevalence and Associated Factors.

Authors:  Inés Morán-Sánchez; Aurelio Luna; Maria D Pérez-Cárceles
Journal:  Psychiatr Q       Date:  2016-03

5.  Factors Influencing Perceived Helpfulness and Participation in Innovative Research: A Pilot Study of Individuals with and without Mood Symptoms.

Authors:  Jane Paik Kim; Tenzin Tsungmey; Maryam Rostami; Sangeeta Mondal; Max Kasun; Laura Weiss Roberts
Journal:  Ethics Behav       Date:  2021-09-22

6.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06

7.  Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Authors:  Laura B Dunn; Daniel S Kim; Ian E Fellows; Barton W Palmer
Journal:  Schizophr Bull       Date:  2008-02-14       Impact factor: 9.306

8.  Cognitive impairment and PD patients' capacity to consent to research.

Authors:  Jason Karlawish; Mark Cary; Stephen T Moelter; Andrew Siderowf; Elizabeth Sullo; Sharon Xie; Daniel Weintraub
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

9.  Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial.

Authors:  Dilip V Jeste; Barton W Palmer; Shahrokh Golshan; Lisa T Eyler; Laura B Dunn; Thomas Meeks; Danielle Glorioso; Ian Fellows; Helena Kraemer; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

10.  Capacity, Vulnerability, and Informed Consent for Research.

Authors:  Michelle Biros
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.